Appointment of Director

RNS Number : 2284X

Cambridge Cognition Holdings PLC

09 January 2014

 



Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Appointment of Director

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces the appointment of Eric Dodd as a Non-Executive Director ('NED') of the Company with immediate effect.

Eric Dodd, aged 44, brings significant experience in board-level positions to the Company, including having been Chief Financial Officer of Antisoma plc between 2008 and 2011. Currently, Mr Dodd acts as Chief Financial Officer of Stanmore Implants Worldwide Holdings Limited, a rapidly growing medical devices company supported by venture capital investors, where he is responsible for the finance, funding, corporate development and investor relations activities of the business. Previously Mr Dodd held positions in three FTSE 100 companies across the pharmaceutical, leisure and IT sectors. Mr Dodd will serve as Chair of the Company's Remuneration Committee. Information in respect of Mr Dodd as required by Schedule 2(g) of the AIM Rules for Companies are included below.

Jane Worlock, Chairman of Cambridge Cognition, said: "Eric brings significant corporate and financial experience and knowledge, including within public companies, to the board of Cambridge Cognition, and we are pleased that we have been able to attract an individual of his calibre to the Company. We welcome him to the team."

Eric Dodd, Non-Executive Director of Cambridge Cognition, said: "I am delighted to be joining Cambridge Cognition at this exciting stage of its development."

Enquiries:

Cambridge Cognition Holdings plc		www.cambridgecognition.com
Nick Kerton, Chief Executive Officer		Tel: [phone]
Nick Walters, Chief Financial Officer
finnCap Ltd (Nomad and Broker)		Tel: [phone]
Matthew Robinson/Henrik Persson/Simon Hicks	(Corporate Finance)
Simon Starr	(Corporate Broking)
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul Cornelius	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

Additional information:

Eric Stephen Dodd, aged 44, holds no shares in Cambridge Cognition, and other than that as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Dodd's appointment today as Non-Executive Director.

Mr Dodd is, or has been, a director of the following companies during the previous five years:

Current Directorships	Directorships in the last five years
Stanmore Implants Worldwide Holdings Ltd	Antisoma plc

About Cambridge Cognition

Cambridge Cognition is a world leading provider of computerised cognitive assessment products.  The company's range of touch-screen CANTAB™ neuropsychological tests, highly validated over one thousand peer-review publications, are used by both academic  scientists  in their research, and clinical researchers in the pharmaceutical industry, to maximise knowledge of cognitive function.  In addition, the company is committed to broadening the access to this technology and is developing clinical healthcare products under the CANTABmobile brand, to improve the monitoring, management and maintenance of cognitive health and wellbeing.  Using these assessments, clinicians can identify and stratify patients so that patient referrals are accurate and efficient, enabling health and social care providers to deliver more effective advice, treatments and care - leading to better outcomes for patients and their families. 

 

END

 

 

BOAQKFDKOBKDBDK